Wyeth Presents New Phase 3 Data And Updates Regulatory Timing For NDA Filing Of Bazedoxifene/Conjugated Estrogens

Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), presented new data from two Phase 3 studies, which showed that bazedoxifene/conjugated estrogens reduced the number and severity of hot flashes in symptomatic postmenopausal women by up to 80 percent, when compared with placebo. These data, presented at the North American Menopause Society Annual Meeting, also showed that bazedoxifene/conjugated estrogens improved symptoms of vulvar and vaginal atrophy. [click link for full article]

More: continued here

Comments are closed.



Online Antibiotics - Buy Drugs: Online Antibiotics
Order pills online - : Order pills online
Privacy rx pills - : Get Privacy rx pills
RX Pharmacy Online - Buy Drugs: RX Pharmacy online
RX Pharmacy Online - Buy Drugs: RX Pharmacy Online
Rx Pill Pharmacy - Rx Pill Pharmacy: Pharmacy for RX pill
RX Store Online - Buy Drugs: RX Store Online
Buy Cool RX - Order Pharmacy Drugs Online: Order Cool Pharmacy Drugs Online.
Happy RX Buy - Happy RX Buy: Happy RX Buy
Medicine Value - Medicine Value: Value the medicine advice
Privacy plus prescriptions - : Privacy plus prescriptions
The world pharmacy - : The world pharmacy
Latest News...